Parallel import of medicine refers to import of original pharmaceuticals from one EU country to repack, relabel, and resell in another EU country, offering the exact same product at a more affordable price.

Parallel import means more affordable prices for consumers, as the medicine is often sold at a more affordable price compared to the domestically sourced alternative. This makes essential pharmaceuticals both more accessible and affordable for consumers, while also reducing the expense for the public healthcare systems.

Parallel imported medicine is the exact same as the original, but in a new package with patient information leaflets in your local language.

Building on our established UK parallel trade services and our successful Generics portfolio in EU, Orifarm UK successfully launched the first of our UK Generics portfolio in May 2025 with more in the pipeline.

Orifarm Generics are high quality alternatives to branded pharmaceuticals. Our generic products are either manufactured in our fully owned GMP manufacturing facilities or through qualified, approved manufacturing partners.

The need for treatment is not always linked to pharmaceuticals already available with a traditional marketing authorization in the patient's country. To support patients in need, we use our strong and extensive experience of trading medicines to deliver pharmaceuticals through special authorization from local authorities. This is known as Unlicensed Medicine.

As the largest parallel import player in the EU, we have unparalleled access to suppliers and markets, allowing us to source the treatments needed when they are needed the most; fast, safe, and reliable.

We source from highly trusted sources, and that's why our partners have trusted our deliveries for almost 30 years.

Clinical trials are essential for developing healthcare treatments. We contribute to the development by sourcing pharmaceuticals used as comparators and co-medications in clinical trials.

Using our position as one of Europe’s largest traders in pharmaceutical products, we are able to shift the procurement dynamics from the standard transactional approach to a data- and market-intelligence-driven supply chain, making sourcing more reliable for the companies performing clinical trials as part of developing new treatments.

At Orifarm Clinical Trial Supplies (CTS), we recognize that the best supply chains are the ones that no-one talks about.

We take pride in our transparent and reliable services that keep clinical trial supplies off the critical path and out of the spotlight.

We’ll take care of your sourcing requirements so that study teams can remain focused on patient recruitment and bring life changing treatments to market.